Skip to main content
CALQUENCE 100 mg/1 capsule, gelatin coated by AstraZeneca Pharmaceuticals LP
CALQUENCE, 100 mg/1, capsule, gelatin coated Drug class: Kinase Inhibitor. Available on prescription only. Listed by AstraZeneca Pharmaceuticals LP.
Prescription only

CALQUENCE

Acalabrutinib

Listed by AstraZeneca Pharmaceuticals LP

Strength
100 mg/1
Form
Capsule, Gelatin Coated
Route
Oral
Class
Kinase Inhibitor

What it contains

  • Acalabrutinib 100 mg/1

FDA record

Dosage form Capsule, Gelatin Coated
Route Oral
Drug class Kinase Inhibitor
Approval route NDA — original brand approval
NDC code 0310-0512
FDA application NDA210259
RxNorm concept 1986813
Marketed since October 2017

Other products containing Acalabrutinib

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

CALQUENCE

acalabrutinib

Strength
100 mg/1
Form
Tablet, Film Coated
Class
Kinase Inhibitor
Rx only

AstraZeneca Pharmaceuticals LP

$543.38 We supply Acaone 100 mg (1 bottle / 30 caps) View product

CALQUENCE

acalabrutinib

Strength
100 mg/1
Form
Tablet, Film Coated
Class
Kinase Inhibitor
Rx only

AstraZeneca Pharmaceuticals LP

$543.38 We supply Acaone 100 mg (1 bottle / 30 caps) View product

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.